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Although severe infections with beta-hemolytic streptococci in dogs have been known since the late 1930s, *Streptococcus canis* was first described taxonomically in 1986 ([@B1]). *S. canis* is considered to be a facultative pathogen, which is normally found to colonize the mucosal surfaces and the skin of its primary hosts, dogs and cats, but without causing disease ([@B2]). Under immunosuppressive conditions and stress, *S. canis* is capable of establishing infections ranging from self-limiting alterations of the skin to severe and life-threatening diseases, such as septicemia, meningitis, streptococcal toxic shock-like syndrome, and necrotizing fasciitis ([@B3][@B4][@B6]). Notably, *S. canis* has also been classified as an emerging zoonotic agent associated with ulcers, endocarditis, and septicemia in humans both with and without prior dog contact ([@B7][@B8][@B10]). However, the number of bacterial isolates from cases of humans suffering from *S. canis* infections remains low in Germany.

Knowledge about the pathogenesis of *S. canis* is scant and relies mostly on comparative phenotypic and genotypic studies to the well-known and closely related human-pathogenic *Streptococcus pyogenes*. Recently, we described the *S. canis* M protein SCM as an important virulence factor that facilitates antiphagocytic activity by plasminogen and nonopsonic IgG binding ([@B11], [@B12]). In addition, *S. canis* is able to immobilize the host's broad-spectrum serine protease plasmin at the bacterial surface that allows degradation of semisynthetic fibrin thrombi, a pathogenesis mechanism to disseminate and spread into the host ([@B13]).

Here, we present the first draft genome sequence of an *S. canis* strain (G361) isolated from humans. The patient was a 40-year-old female from Lower Saxony, Germany, who suffered a premature membrane rupture during pregnancy. The bacterial strain was obtained from a vaginal swab and stored at the German National Reference Center for Streptococci, University Hospital RWTH Aachen.

The 75-bp paired-end reads were generated using an Illumina Genome Analyzer IIx sequencer. The reads were *de novo* assembled into contigs with a minimum size of 500 bp using SPAdes ([@B14]). A total of 62 contigs were generated ranging from 630 bp to 191,491 bp, resulting in a total genome size of 2,045,931 bp. The cumulative G+C content of the genome assembly was 39.6%. Gene annotation was performed using the Rapid Annotations using Subsystems Technology (RAST) annotation server ([@B15]), which predicted 2,028 coding DNA sequences, 36 tRNAs, and 3 rRNAs in the draft genome. The typical streptococcal virulence-associated genes encoding, e.g., a fibronectin-binding protein, proteins involved in streptolysin S biosynthesis, the previously mentioned SCM protein (antiphagocytic M protein), and an IgG-endopeptidase-related protein were identified in the G361 draft genome. G361 was assigned to sequence type 13 (ST-13) using the multilocus sequence typing service for total-genome-sequenced bacteria from the Center for Genomic Epidemiology ([@B16]). No acquired antimicrobial resistance genes were identified within the genome sequences using ResFinder ([@B17]). This confirmed the results obtained with the bioMérieux Vitek 2 system, which did not identify any phenotypic resistances to ampicillin, benzyl-penicillin, cefotaxime, ceftriaxone, clindamycin, erythromycin, levofloxacin, linezolid, tetracycline, trimethoprim-sulfamethoxazole, or vancomycin.
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This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number [NMRV00000000](https://www.ncbi.nlm.nih.gov/nuccore/NMRV00000000). The version described in this paper is the first version, NMRV01000000.
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